Osalmid Inhibits the Progression of Lung Adenocarcinoma and Sensitizes It to EGFR-TKIs: A Preclinical and Translational Study

被引：0
|
作者：
Wu, L. -L. [1 ]
Jiang, W. -M. [1 ]
Wang, R. -R. [2 ]
Xie, D. [2 ]
机构：
[1] Zhejiang Canc Hosp, Hangzhou, Peoples R China
[2] Shanghai Pulm Hosp, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.03I.14
引用
收藏
页码：S315 / S315
页数：1
相关论文
共 50 条
  • [41] Predictive value of direct bilirubin and total bile acid in lung adenocarcinoma patients treated with EGFR-TKIs
    Li, Yuting
    Wang, Bicheng
    Fei, Shihong
    Qin, You
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [42] The functional MDM4 genetic variant in advanced lung adenocarcinoma patients treated with EGFR-TKIs
    Zhang, N.
    Yang, M.
    Xing, H.
    Liu, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [43] Potential Mechanism Revealed by Targeted Sequencing from Lung Adenocarcinoma Patients with Primary Resistance to EGFR-TKIs
    Zhong, Jia
    Zhang, Yanyan
    Wang, Zhijie
    Bai, Hua
    Wang, Jie
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1265 - S1265
  • [44] Paeoniae radix overcomes resistance to EGFR-TKIs via aurora B pathway suppression in lung adenocarcinoma
    Yeo, Heerim
    Lee, Haeseung
    Park, Sang-Min
    Kang, Han Na
    LIFE SCIENCES, 2024, 357
  • [45] Small cell lung cancer transformation after EGFR-TKIs treatment in lung adenocarcinoma: A case report and literatures review
    Chen, Xiaoli
    Li, Dongmei
    Miao, Kun
    Shou, Tao
    Zhang, Wenjing
    MEDICINE, 2023, 102 (04) : E32697
  • [46] Bevacizumab Combined with Continuation of EGFR-TKIs in NSCLC Beyond Gradual Progression
    Xu, Ziyi
    Teng, Fei
    Hao, Xuezhi
    Li, Junling
    Xing, Puyuan
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 1891 - 1902
  • [47] Thick-wall cavity predicts worse progression-free survival in lung adenocarcinoma treated with first-line EGFR-TKIs
    Zhou, Fei
    Ma, Wanrong
    Li, Wei
    Ni, Huijuan
    Gao, Guanghui
    Chen, Xiaoxia
    Zhang, Jie
    Shi, Jingyun
    BMC CANCER, 2018, 18
  • [48] Thick-wall cavity predicts worse progression-free survival in lung adenocarcinoma treated with first-line EGFR-TKIs
    Fei Zhou
    Wanrong Ma
    Wei Li
    Huijuan Ni
    Guanghui Gao
    Xiaoxia Chen
    Jie Zhang
    Jingyun Shi
    BMC Cancer, 18
  • [49] Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasis
    Chen, Yanxin
    Wei, Jianping
    Cai, Jing
    Liu, Anwen
    BMC CANCER, 2019, 19 (01)
  • [50] Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasis
    Yanxin Chen
    Jianping Wei
    Jing Cai
    Anwen Liu
    BMC Cancer, 19
12345